Okabe-Kado J - Search Results

1

Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma.

Niitsu N, Okamoto M, Okabe-Kado J, Takagi T, Yoshida T, Aoki S, Honma Y, Hirano M. Niitsu N, et al. Leukemia. 2001 May;15(5):832-9. doi: 10.1038/sj.leu.2402105. Leukemia. 2001. PMID: 11368446

2

Expression of cell surface NM23 proteins of human leukemia cell lines of various cellular lineage and differentiation stages.

Okabe-Kado J, Kasukabe T, Honma Y. Okabe-Kado J, et al. Leuk Res. 2002 Jun;26(6):569-76. doi: 10.1016/s0145-2126(01)00171-0. Leuk Res. 2002. PMID: 12007505

3

Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma.

Niitsu N, Nakamine H, Okamoto M, Akamatsu H, Honma Y, Higashihara M, Okabe-Kado J, Hirano M; Adult Lymphoma Treatment Study Group, ALTSG. Niitsu N, et al. Br J Haematol. 2003 Nov;123(4):621-30. doi: 10.1046/j.1365-2141.2003.04668.x. Br J Haematol. 2003. PMID: 14616965 Free article.

4

Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphoma.

Niitsu N, Nakamine H, Okamoto M, Akamatsu H, Higashihara M, Honma Y, Okabe-Kado J, Hirano M. Niitsu N, et al. Clin Cancer Res. 2004 Apr 1;10(7):2482-90. doi: 10.1158/1078-0432.ccr-03-0085. Clin Cancer Res. 2004. PMID: 15073128

5

Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia.

Okabe-Kado J, Kasukabe T, Honma Y. Okabe-Kado J, et al. Leuk Lymphoma. 1998 Dec;32(1-2):19-28. doi: 10.3109/10428199809059243. Leuk Lymphoma. 1998. PMID: 10036998 Review.

6

Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.

Niitsu N, Okabe-Kado J, Kasukabe T, Yamamoto-Yamaguchi Y, Umeda M, Honma Y. Niitsu N, et al. Blood. 1999 Nov 15;94(10):3541-50. Blood. 1999. PMID: 10552965 Free article.

7

Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.

Niitsu N, Okabe-Kado J, Nakayama M, Wakimoto N, Sakashita A, Maseki N, Motoyoshi K, Umeda M, Honma Y. Niitsu N, et al. Blood. 2000 Aug 1;96(3):1080-6. Blood. 2000. PMID: 10910925 Free article.

8

Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.

Niitsu N, Okabe-Kado J, Okamoto M, Takagi T, Yoshida T, Aoki S, Hirano M, Honma Y. Niitsu N, et al. Blood. 2001 Mar 1;97(5):1202-10. doi: 10.1182/blood.v97.5.1202. Blood. 2001. PMID: 11222361 Free article.

9

Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome.

Ito Y, Okabe-Kado J, Honma Y, Iwase O, Shimamoto T, Ohyashiki JH, Ohyashiki K. Ito Y, et al. Leukemia. 2002 Feb;16(2):165-9. doi: 10.1038/sj.leu.2402370. Leukemia. 2002. PMID: 11840281

10

Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.

Niitsu N, Honma Y, Iijima K, Takagi T, Higashihara M, Sawada U, Okabe-Kado J. Niitsu N, et al. Leukemia. 2003 Jan;17(1):196-202. doi: 10.1038/sj.leu.2402699. Leukemia. 2003. PMID: 12529678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters